Work Medical Technology Group Ltd Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Fiscal Year 2026 Annual Report (Form 20-F) Filing | 31 Jan 2027 |
Monitoring Framework
Key Performance Indicators
Net Revenue Annually9.9M
Gross Profit Margin Annually23.8%
Net Income Annually-1.1M
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price below $1.00 for 30 consecutive business daysAction: Implement reverse stock splits or other capital restructuring measures to maintain listing status.
- U.S. Market Expansion via Work Bio Technologies LtdTrigger: Direct operational presence and supply chain integration milestones in the U.S.Action: Monitor commercialization progress, regulatory compliance, and customer engagement metrics.
Research as of 20 Jun 2026